Pricing Log in Create free account
Friday 6 November 2026 Export REGN’s income statement to Excel — free account

Regeneron Pharmaceuticals, Inc.

REGN Healthcare Biotechnology

Regeneron Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.3 billion, up 0.99% from fiscal 2024.

Revenue
+36.3%
EPS
+36.0%
Free cash flow
+3.85%
Total debt
−26.6%

Quarter to September 2026, against a year earlier

905.02 2.12 +0.23%
Market cap
$93.4B
P/E
19.2×
Fwd P/E
19.2×
Dividend yield
0.41%
F-score
5/9
Altman Z
7.49
Beneish M
−2.53
Dividend safety
77/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Regeneron Pharmaceuticals, Inc. (REGN) Current ratio

Alert me on Current ratio

Regeneron Pharmaceuticals, Inc.'s current ratio at the end of the quarter to 30 September 2026 was 3.4×, down 0.8× from fiscal 2025 (4.1×). Over the past ten years it has ranged from 2.6× (fiscal 2016) to 5.7× (fiscal 2023); the current reading is higher than 64% of that period. That is below the Biotechnology industry median of 4.9× and above the Healthcare sector median of 3.1×.

Current ratio, annual

Embed this chart

Annual newest first

Period Current ratio Change
FY2025 4.1× (12.80%)
FY2024 4.7× (16.85%)
FY2023 5.7× 12.53%
FY2022 5.1× 41.88%
FY2021 3.6× (1.70%)
FY2020 3.6× (1.15%)
FY2019 3.7× (17.93%)
FY2018 4.5× 17.05%
FY2017 3.8× 49.04%
FY2016 2.6× (28.72%)

Quarterly newest first

Period Current ratio Change
Sep 2026 3.4× 0.53%
Jun 2026 3.3× (6.44%)
Mar 2026 3.6× (13.59%)
Dec 2025 4.1× 1.53%
43 more quarters

Against its own ten years

Low 2.6× High 5.7×
Ten-year median 3.8×
Current reading's percentile 64

Current ratio against peers

Company Current ratio
ROIV Roivant Sciences Ltd. compare 16.7×
RVMD Revolution Medicines, Inc. compare 8.4×
ARGX argenex SE compare 5.1×
ONC BeOne Medicines Ltd. - Sponsored ADR compare 3.6×
REGN Regeneron Pharmaceuticals, Inc. 3.4×
GMAB Genmab A/S Sponsored ADR compare 2.5×
VRTX Vertex Pharmaceuticals Incorporated compare 2.3×
MRNA Moderna, Inc. compare 2.3×
RPRX Royalty Pharma PLC compare 1.3×
Biotechnology industry median 4.9×
Healthcare sector median 3.1×
Market median 1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on REGN